Ronald de Vries

Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study

Anas Younes, Catherine Thiéblemont, Franck Morschhauser et al. · The Lancet Oncology · 2014 · 250 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +6

A Device for Dried Blood Microsampling in Quantitative Bioanalysis: Overcoming The Issues Associated Blood Hematocrit

Neil Spooner, Philip Denniff, L. Michielsen et al. · Bioanalysis · 2014 · 216 citations · Full text

The Effect of Hematocrit on Bioanalysis of DBS: Results from The EBF DBS-Microsampling Consortium

Ronald de Vries, Matthew Barfield, Nico van de Merbel et al. · Bioanalysis · 2013 · 129 citations

Update of The EBF Recommendation for The Use of DBS in Regulated Bioanalysis Integrating The Conclusions from The EBF DBS-Microsampling Consortium

Philip Timmerman, Steve White, Zoe Cobb et al. · Bioanalysis · 2013 · 110 citations

Engineering, Biomolecular Tool, Dbs Technology +28

Effect of <scp>CYP</scp>3A perpetrators on ibrutinib exposure in healthy participants

Jan de Jong, Donna Skee, Joe Murphy et al. · Pharmacology Research & Perspectives · 2015 · 98 citations · Full text